Search filters

List of works by Rafal Stec

Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?

scientific article

Axitinib in sequential therapy in metastatic renal cell carcinoma.

scientific article published on 20 December 2016

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.

scientific article

Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

scientific article published on 07 October 2009

Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines

scientific article published on 10 May 2015

Colorectal cancer in the course of familial adenomatous polyposis syndrome ("de novo" pathogenic mutation of APC gene): case report, review of the literature and genetic commentary

scientific article published on April 2010

Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer.

scientific article published on 17 August 2010

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

scientific article published on 20 June 2016

Editorial comment to Chromophobe renal cell carcinoma: a review of an uncommon entity

scientific article published on 04 September 2012

Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis

scientific article published on 20 August 2009

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors

scientific article

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

scientific article published on 01 October 2020

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model

scientific article published on 3 March 2017

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

scientific article

Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer

scientific article published on 19 June 2019

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

scientific article

Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review).

scientific article

Milestones in the treatment of hepatocellular carcinoma: A systematic review

scientific article published on 18 November 2020

Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial

scientific article

Molecular differences in the KRAS gene mutation between a primary tumor and related metastatic sites - case report and a literature review.

scientific article published on December 2010

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer

scientific article

Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, and C-reactive Protein as New and Simple Prognostic Factors in Patients With Metastatic Renal Cell Cancer Treated With Tyrosine Kinase Inhibitors: A Systemic Review and Meta-analysis.

scientific article published on 2 February 2018

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

scientific article published on 24 July 2013

Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors

scientific article published in January 2018

Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

scientific article

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: the prediction value of ERCC1 and Tau expression

scientific article published on 27 February 2014

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines

scientific article published on 02 February 2018

Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer

scientific article published on 01 April 2020

Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.

scientific article published on August 2009

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.

scientific article published on 30 April 2013

The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?

scientific article published on 15 July 2019

The role of Tau protein in resistance to paclitaxel

scientific article published on 29 June 2011

Paulina is supported by:

About Paulina

Help